Lloret, A.

Pennisi, M.G.

Ferrer, L.

Addie, D.

Belák, S.

Boucraut-Baralon, C.

Egberink, H.F.

Frymus, T.

Gruffydd-Jones, T.

Hosie, M.J.

Lutz, H.

Marsilio, F.

Möstl, K.

Radford, A.D.

Thiry, E.

Truyen, U.

Horzinek, M.C.

Strategic Infection Biology

Dep Infectieziekten Immunologie

Journal of Feline Medicine and Surgery

Overview: Phaeohyphomycoses and hyalohyphomycoses are rare opportunistic infections acquired from the environment. More cases have been reported in recent years in humans and cats. Disease signs: Single or multiple nodules or ulcerated plaques (which may be pigmented) in the skin are the typical lesions. In some cases the infection disseminates or involves the central nervous system (CNS). Diagnosis: Diagnosis is based on fungal detection by cytology and/or histology. Culture provides definitive diagnosis and species identification. Treatment: Treatment involves surgical excision in cases of localised skin disease followed by systemic antifungal therapy, with itraconazole as the agent of first choice. Relapses after treatment are common. Itraconazole and other systemic antifungal agents have been used to treat systemic or neurological cases, but the response is unpredictable. The prognosis is guarded to poor in cats with multiple lesions and systemic or neurological involvement. Zoonotic risk: There is no zoonotic risk associated with contact with infected cats. </jats:sec

Albert Lloret

Katrin Hartmann

Maria Grazia Pennisi

Lluis Ferrer

Diane Addie

Sándor Belák

Corine Boucraut-Baralon

Herman Egberink

Tadeusz Frymus

Tim Gruffydd-Jones

Margaret J Hosie

Hans Lutz

Fulvio Marsilio

Karin Möstl

Alan D Radford

Etienne Thiry

Uwe Truyen

Marian C Horzinek

Crossref

Rare opportunistic mycoses in cats: phaeohyphomycosis and hyalohyphomycosis

Utrecht University Repository

RARE OPPORTUNISTIC MYCOSES IN CATS: PHAEOHYPHOMYCOSIS AND HYALOHYPHOMYCOSIS ABCD guidelines on prevention and management

OVERVIEW: Phaeohyphomycoses and hyalohyphomycoses are rare opportunistic infections acquired from the environment. More cases have been reported in recent years in humans and cats.

DISEASE SIGNS: Single or multiple nodules or ulcerated plaques (which may be pigmented) in the skin are the typical lesions. In some cases the infection disseminates or involves the central nervous system (CNS).

DIAGNOSIS: Diagnosis is based on fungal detection by cytology and/or histology. Culture provides definitive diagnosis and species identification.

TREATMENT: Treatment involves surgical excision in cases of localised skin disease followed by systemic antifungal therapy, with itraconazole as the agent of first choice. Relapses after treatment are common. Itraconazole and other systemic antifungal agents have been used to treat systemic or neurological cases, but the response is unpredictable. The prognosis is guarded to poor in cats with multiple lesions and systemic or neurological involvement. ZOONOTIC RISK: There is no zoonotic risk associated with contact with infected cats

Lloret, Albert

Hartmann, Katrin

Pennisi, Maria Grazia

Ferrer, Lluis

Addie, Diane

Belák, Sándor

Boucraut-Baralon, Corine

Egberink, Herman

Frymus, Tadeusz

Gruffydd-Jones, Tim

Hosie, Margaret J

Lutz, Hans

Marsilio, Fulvio

Möstl, Karin

Radford, Alan D

Thiry, Etienne

Truyen, Uwe

Horzinek, Marian C

ZORA

Rare opportunistic mycoses in cats: phaeohyphomycosis and hyalohyphomycosis: ABCD guidelines on prevention and management

LLoret,

Hartmann, K.

Belak, S.

Egberink, H.

Gruffydd-Jones,

Open Repository and Bibliography - Liège

Rare opportunistic mycoses in cats : phaeohyphomycosis and hyalohyphomycosis : ABCD guidelines on prevention and management

OVERVIEW:

Phaeohyphomycoses and hyalohyphomycoses are rare opportunistic infections acquired from the environment. More cases have been reported in recent years in humans and cats.
DISEASE SIGNS:

Single or multiple nodules or ulcerated plaques (which may be pigmented) in the skin are the typical lesions. In some cases the infection disseminates or involves the central nervous system (CNS).
DIAGNOSIS:

Diagnosis is based on fungal detection by cytology and/or histology. Culture provides definitive diagnosis and species identification.
TREATMENT:

Treatment involves surgical excision in cases of localised skin disease followed by systemic antifungal therapy, with itraconazole as the agent of first choice. Relapses after treatment are common. Itraconazole and other systemic antifungal agents have been used to treat systemic or neurological cases, but the response is unpredictable. The prognosis is guarded to poor in cats with multiple lesions and systemic or neurological involvement. ZOONOTIC RISK: There is no zoonotic risk associated with contact with infected cats

Rare opportunistic mycoses in cats : phaeohyphomycosis and hyalohyphomycosis : ABCD guidelines on prevention and management

Abstract

Similar works

Full text

Available Versions

Crossref

Utrecht University Repository

ZORA

Open Repository and Bibliography - Liège

Archivio della Ricerca - Università degli Studi di Teramo

NARCIS